Denali Therapeutics Inc. (DNLI) earnings date
Feb 25, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 37 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 3, 2026 | after close | 34 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | after close | 37 | 8-K |
| Q1 FY2026 | Thu, May 7, 2026 | after close | 37 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | after close | 57 | 8-K |
| Q3 FY2025 | Thu, Nov 6, 2025 | after close | 37 | 8-K |
| Q2 FY2025 | Mon, Aug 11, 2025 | after close | 42 | 8-K |
| Q1 FY2025 | Tue, May 6, 2025 | after close | 36 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | after close | 58 | 8-K |
What they guided beta
| Q3 FY2026 | "Continued growth expectations drive Q4 2026 net product revenue guidance of $30.0 million to $32.0 million" exhibit |
| Q3 FY2026 | "Five TransportVehicle™ (TV) programs expected to generate data in 2027: zafinofusp alfa (ETV:SGSH), DNL593 (PTV:PGRN), DNL628 (OTV:MAPT), DNL921 (ATV:Abeta) and DNL952 (ETV:GAA)" exhibit |
| Q3 FY2026 | "Fourth-quarter 2026 net product revenue is expected to be $30.0 million to $32.0 million." exhibit |
| Q3 FY2026 | "Data from the COMPASS study are expected in the first half of 2028." exhibit |
| Q3 FY2026 | "Data are expected in the first half of 2027." exhibit |
| Q2 FY2026 | "Projected third-quarter 2026 AVLAYAH net product revenue is $10.0 million to $12.0 million." exhibit |
| Q2 FY2026 | "Denali expects a Biologics License Application (BLA) submission and potential accelerated approval for zafinofusp alfa for Sanfilippo syndrome type A in 2027." exhibit |
| Q2 FY2026 | "Denali now expects results from the study in 2027, updated from its prior expectation of results by the end of 2026." exhibit |
| Q2 FY2026 | "Dosing of participants with late-onset Pompe disease began in the Phase 1 study of DNL952 in the second quarter of 2026, and initial clinical data are expected in 2027." exhibit |
| Q2 FY2026 | "Initial clinical biomarker data from the ongoing Phase 1b study of DNL628 in participants with Alzheimer’s disease are expected in the first half of 2027. 2 DNL921 (ATV:Abeta) for Alzheimer's disease DNL921 is an investigational Antibody TransportVehicle ™ (ATV)-enabled antibody designed for systemic delivery across the blood-brain barrier to target amyloid plaques in Alzheimer's disease." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/DNLI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/DNLI
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/DNLI/"><img src="https://veritasdata.dev/embed/DNLI.svg" alt="DNLI earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/DNLI/)
Script
<script async src="https://veritasdata.dev/embed/DNLI.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/DNLI"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.